Evaluation of screening-detected lung nodules: Minimising the risk of unnecessary biopsy and surgery

Thorax

Volumn 66, Issue 4, 2011, Pages 277-279

  Gould, Michael K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER GROWTH; CANCER SCREENING; CLINICAL PRACTICE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; EDITORIAL; FALSE POSITIVE RESULT; HUMAN; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SAFETY; SENSITIVITY AND SPECIFICITY; SURGICAL RISK; VIDEO ASSISTED THORACOSCOPIC SURGERY; VOLUME DOUBLING TIME;

EID: 79953027430     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.142067     Document Type: Editorial

References (23)

1. Obuchowski NA, Graham RJ, Baker ME, et al. Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers. Am J Roentgenol 2001;176:1357-62. (Pubitemid 32510241)
2. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99-105. (Pubitemid 29313143)
3. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-13. (Pubitemid 34165474)
4. Van Israel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomized lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74. (Pubitemid 46175408)
5. Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT baseline results of the randomized DANTE trial. Lung Cancer 2008;59:355-63. (Pubitemid 351335108)
6. Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round. J Thorac Oncol 2009;4:608.
7. Smith-Bindman R. Is computed tomography safe? N Engl J Med 2010;363:1-4.
8. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009;169:2078-86.
9. Berrington de Gonza lez A, Mahesh M, Kim K-P, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009;169:2071-7.
10. Wahidi MM, Gover JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? An ACCP evidence-based clinical practice guideline (2nd edition). Chest 2007;132:94-107S.
11. Gould MK, Wiener RS. Shared decision making in patients with pulmonary nodules. pulmonary, critical care, Sleep Update (PCCSU) 2009;23(Lesson 19). http://www.chestnet.org/accp/pccsu (accessed 17 Aug 2010).
12. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400. (Pubitemid 41507873)
13. Collins VP, Loefler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol 1956;76:988-1000.
14. Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1962;79:221-31.
15. Weiss W, Boucot KR, Cooper DA. Growth rate in the detection and prognosis of bronchogenic carcinoma. JAMA 1966;198:1246-52.
16. Steele JD, Buell P. Asymptomatic solitary pulmonary nodules: host survival, tumor size, and growth rate. J Thorac Cardiovasc Surg 1973;65:140-51.
17. Geddes DM. The natural history of lung cancer: a review based on rates of tumor growth. Br J Dis Chest 1979;73:1-17. (Pubitemid 9097173)
18. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217:251-6. (Pubitemid 33097610)
19. Winer-Muram HT, Jennings SG, Tarver RD, et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 2002;223:798-805. (Pubitemid 34547600)
20. Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 2000;41:85-92. (Pubitemid 30046688)
21. Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008;3:6-12.
22. Ashraf H, Mortensend J, Dirksen A, et al. Combined use of PET and volume doubling time in lung cancer screening with low dose CT. Thorax 2011;66:315-19.
23. Van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.